Mesa Laboratories (MLI) Ratios
Mesa Laboratories Ratios
DE:MLI's free cash flow for Q1 2027 was $14.18M. For the 2027 fiscal year, DE:MLI's free cash flow was decreased by $-559.00K and operating cash flow was $14.74M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.72 | 0.63 | 2.47 | 2.74 | 2.59 |
| Quick Ratio | 1.29 | 0.47 | 1.73 | 1.94 | 2.07 |
| Cash Ratio | 0.44 | 0.17 | 0.64 | 0.76 | 1.03 |
| Solvency Ratio | 0.12 | 0.08 | -0.74 | 0.13 | 0.09 |
| Operating Cash Flow Ratio | 0.69 | 0.29 | 1.00 | 0.65 | 0.82 |
| Short-Term Operating Cash Flow Coverage | 7.61 | 0.46 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -135.23M | $ -170.83M | $ -192.05M | $ -149.38M | $ -189.25M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.39 | 0.42 | 0.52 | 0.28 | 0.31 |
| Debt-to-Equity Ratio | 0.91 | 1.14 | 1.59 | 0.47 | 0.56 |
| Debt-to-Capital Ratio | 0.48 | 0.53 | 0.61 | 0.32 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.44 | 0.32 | 0.60 | 0.32 | 0.36 |
| Financial Leverage Ratio | 2.30 | 2.71 | 3.07 | 1.68 | 1.80 |
| Debt Service Coverage Ratio | 1.84 | 0.30 | -38.09 | 8.14 | 7.93 |
| Interest Coverage Ratio | 1.73 | 1.38 | -47.76 | 0.70 | 1.21 |
| Debt to Market Cap | 0.31 | 0.28 | 0.37 | 0.20 | 0.16 |
| Interest Debt Per Share | 32.56 | 35.61 | 44.00 | 35.88 | 43.17 |
| Net Debt to EBITDA | 4.02 | 3.64 | -0.85 | 4.08 | 5.28 |
| Profitability Margins | |||||
| Gross Profit Margin | 63.53% | 62.61% | 61.64% | 61.02% | 59.18% |
| EBIT Margin | 4.82% | 7.39% | -124.87% | 2.00% | 4.05% |
| EBITDA Margin | 14.16% | 17.57% | -110.26% | 17.12% | 17.65% |
| Operating Profit Margin | 7.43% | 6.78% | -125.85% | 1.52% | 2.55% |
| Pretax Profit Margin | 4.82% | 2.47% | -127.50% | -0.18% | 1.94% |
| Net Profit Margin | 2.69% | -0.82% | -117.60% | 0.42% | 1.01% |
| Continuous Operations Profit Margin | 2.69% | -0.82% | -117.60% | 0.42% | 1.01% |
| Net Income Per EBT | 55.87% | -33.12% | 92.24% | -239.07% | 52.35% |
| EBT Per EBIT | 64.90% | 36.49% | 101.31% | -11.72% | 76.01% |
| Return on Assets (ROA) | 1.57% | -0.46% | -56.90% | 0.14% | 0.26% |
| Return on Equity (ROE) | 3.60% | -1.24% | -174.87% | 0.24% | 0.48% |
| Return on Capital Employed (ROCE) | 5.06% | 6.06% | -67.60% | 0.54% | 0.71% |
| Return on Invested Capital (ROIC) | 2.76% | -1.45% | -61.89% | -1.28% | 0.37% |
| Return on Tangible Assets | 4.26% | -1.28% | -166.23% | 0.59% | 1.13% |
| Earnings Yield | 1.38% | -0.31% | -42.15% | 0.10% | 0.14% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.65 | 5.74 | 5.54 | 5.15 | 4.47 |
| Payables Turnover | 18.44 | 15.68 | 13.73 | 13.92 | 9.53 |
| Inventory Turnover | 3.45 | 3.55 | 2.54 | 2.46 | 3.06 |
| Fixed Asset Turnover | 5.18 | 7.45 | 5.22 | 7.78 | 6.44 |
| Asset Turnover | 0.58 | 0.56 | 0.48 | 0.33 | 0.26 |
| Working Capital Turnover Ratio | -29.47 | 128.11 | 3.07 | 2.88 | 1.06 |
| Cash Conversion Cycle | 150.76 | 143.04 | 183.15 | 192.75 | 162.68 |
| Days of Sales Outstanding | 64.61 | 63.57 | 65.94 | 70.89 | 81.63 |
| Days of Inventory Outstanding | 105.94 | 102.75 | 143.80 | 148.08 | 119.36 |
| Days of Payables Outstanding | 19.80 | 23.28 | 26.59 | 26.22 | 38.31 |
| Operating Cycle | 170.55 | 166.32 | 209.74 | 218.98 | 200.99 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 7.77 | 8.62 | 8.19 | 5.26 | 7.53 |
| Free Cash Flow Per Share | 7.18 | 7.79 | 7.72 | 4.40 | 6.68 |
| Dividend Paid and CapEx Coverage Ratio | 6.32 | 5.88 | 7.34 | 3.52 | 5.05 |
| Capital Expenditure Coverage Ratio | 13.18 | 10.40 | 17.19 | 6.16 | 8.85 |
| Operating Cash Flow Coverage Ratio | 0.25 | 0.26 | 0.19 | 0.15 | 0.18 |
| Operating Cash Flow to Sales Ratio | 0.17 | 0.19 | 0.20 | 0.13 | 0.21 |
| Free Cash Flow Yield | 8.12% | 6.57% | 6.89% | 2.52% | 2.62% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 72.48 | -329.61 | -2.37 | 999.72 | 710.01 |
| Price-to-Sales (P/S) Ratio | 1.96 | 2.67 | 2.79 | 4.24 | 7.21 |
| Price-to-Book (P/B) Ratio | 2.62 | 4.03 | 4.15 | 2.36 | 3.37 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.32 | 15.23 | 14.51 | 39.67 | 38.18 |
| Price-to-Operating Cash Flow Ratio | 11.38 | 13.76 | 13.67 | 33.23 | 33.87 |
| Price-to-Earnings Growth (PEG) Ratio | -0.17 | 3.32 | 0.00 | -18.94 | -15.62 |
| Enterprise Value Multiple | 17.84 | 18.85 | -3.38 | 28.87 | 46.12 |
| Enterprise Value | 629.45M | 798.36M | 806.32M | 1.08B | 1.50B |
| EV to EBITDA | 17.84 | 18.85 | -3.38 | 28.87 | 46.12 |
| EV to Sales | 2.53 | 3.31 | 3.73 | 4.94 | 8.14 |
| EV to Free Cash Flow | 15.90 | 18.87 | 19.40 | 46.20 | 43.12 |
| EV to Operating Cash Flow | 14.70 | 17.06 | 18.27 | 38.70 | 38.25 |
| Tangible Book Value Per Share | -15.23 | -21.88 | -27.56 | -20.63 | -28.30 |
| Shareholders’ Equity Per Share | 33.78 | 29.44 | 26.99 | 73.95 | 75.56 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.44 | 1.33 | 0.08 | 3.39 | 0.48 |
| Revenue Per Share | 45.18 | 44.39 | 40.14 | 41.17 | 35.37 |
| Net Income Per Share | 1.22 | -0.36 | -47.20 | 0.17 | 0.36 |
| Tax Burden | 0.56 | -0.33 | 0.92 | -2.39 | 0.52 |
| Interest Burden | 1.00 | 0.33 | 1.02 | -0.09 | 0.48 |
| Research & Development to Revenue | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 |
| SG&A to Revenue | 0.48 | 0.48 | 0.34 | 0.33 | 0.33 |
| Stock-Based Compensation to Revenue | 0.07 | 0.05 | 0.06 | 0.06 | 0.06 |
| Income Quality | 6.38 | -23.71 | -0.17 | 30.09 | 20.96 |
Currency in USD